Subject: Baxter Board Clears Strategy to Spin Off Non-Hospital Lines Date: Published: 6/15/92 (45 lines) Source: Wall Street Journal. Copyright Dow Jones & Co. Inc. Business Brief: Baxter Board Clears Strategy to Spin Off Non-Hospital Lines DEERFIELD, Ill. -- Baxter International Inc. said its board approved a plan to spin off its businesses that provide products and services for home care and other non-hospital therapy. The hospital supply concern said shareholders will receive 100% of the new stock of its so-called alternate-site division, which consists of Caremark Inc., the orthopedic services division, and the prescription service division. The company will be called Caremark and its stock will trade separately. The alternate-site business, which provides such services as AIDS care at home, accounts for about 15% of Baxter's sales. Sales in those businesses exceeded $1 billion in 1991 and have been growing more than 20% a year over the past four years. Baxter's renal therapy business isn't included in the spinoff. Baxter said the spinoff is "the best way to achieve the range of objectives that we've set," such as making the businesses more competitive and to resolve conflicts between the alternate-site businesses and its core hospital customers. Baxter sometimes creates hostility at hospitals by seeking to lure patients away. Spinning off the operations, Baxter said, will also permit the company to achieve its earnings and return-to-capital objectives. Baxter's shares have been trading at a price-earnings ratio of about 17, compared with ratios ranging from 21 to 50 for competitors in the alternate-health-care field. Baxter said that while full details of the spinoff haven't been worked out, the transaction is expected to be completed by year end. [This article is made available here by Dow Jones Co. for the personal and non-commercial use of callers to this bbs, in the hope that it will be of some help to those who are suffering from the disease and others who are seeking to help them.]